Preclinical Research

Inspire introduces program to foster research collaboration

09-Sep-2020 By Jenni Spinner

The Inspire Research Accelerator is designed to let academic researchers anywhere in the world to collaborate with the company.

COVID-19 treatment study predicts adverse drug events

03-Sep-2020 By Jenni Spinner

Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.

COVID-19 report shares insights on potential therapies

01-Sep-2020 By Jenni Spinner

A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.

AstraZeneca, World Heart Federation partner on CV solutions

01-Sep-2020 By Jenni Spinner

The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.

Thermo Fisher expands cryo-EM access

31-Aug-2020 By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

Front-line physicians offer COVID-19 insights

31-Aug-2020 By Jenni Spinner

A recent study from healthcare insights company Sermo shares information and perspectives that trial and pharma professionals could learn from.

Veeva report highlights study start-up challenges

25-Aug-2020 By Jenni Spinner

The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.

Centogene database offers rare-disease insights

24-Aug-2020 By Jenni Spinner

The newly expanded CentoMD 5.8 mutation database includes clinical, epidemiologic and phenotypic data from more than 430,000 analyzed cases.

Duchenne foundation funds research leading to first-in-human clinical study

19-Aug-2020 By Jenni Spinner

The research taking place at Nationwide Children’s Hospital is seeking a treatment for a rare Duchenne muscular dystrophy mutation.

Cerba Research: collaboration boosts rare-disease discoveries

19-Aug-2020 By Jenni Spinner

A leader from the clinical laboratory and diagnostic solution provider discusses how its research is fueled by partnerships and patient-centricity.

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Novateur study points toward potential COVID-19 treatment

17-Aug-2020 By Jenni Spinner

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.